AbD Serotec

AbD Serotec, a research and diagnostic division of MorphoSys AG of Martinsried, Germany, and its customer e2v biosensors, a subsidiary of e2v technologies plc of Essex, UK, have developed Visucare, a biosensor program that can identify biomarkers with a single-antibody immunoassay. The system will be combined with AbD Serotec’s HuCAL antibody technology to analyze protein quantification for patient care. E2v technologies is a manufacturer of sensors and semiconductors, and MorphoSys researches antibody technology.





LATEST NEWS

• CLEO Heads to the East Coast
  Apr 29, 2024
• Laser-Based Gas Analyzer Developed to Detect Air Pollution
  Apr 29, 2024
• Qubits Could be Stored in Flash-Like Memory
  Apr 29, 2024
• Exail Signs LLNL Contract, Partners with Eelume
  Apr 26, 2024
• Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
  Apr 26, 2024
• Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
  Apr 25, 2024
• DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
  Apr 25, 2024
• Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
  Apr 24, 2024